,Set,NGenes,Direction,PValue,FDR
1,WP_PROSTAGLANDIN_SIGNALING,24,Down,1.76839222884266e-07,0.000145892358879519
2,WP_SPINAL_CORD_INJURY,64,Down,5.02567957114163e-06,0.00207309282309592
3,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,1.75874471334693e-05,0.00477624260696908
4,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,2.34054009088621e-05,0.00477624260696908
5,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,3.15427101839939e-05,0.00477624260696908
6,WP_POSTCOVID_NEUROINFLAMMATION,13,Down,4.30476439389151e-05,0.00477624260696908
7,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Down,4.34444173723668e-05,0.00477624260696908
8,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Down,4.63150798251547e-05,0.00477624260696908
9,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,41,Down,5.88126444690376e-05,0.00539115907632845
10,WP_HYPERTROPHY_MODEL,13,Down,7.56196082948694e-05,0.00623861768432672
11,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Down,0.000197945585037023,0.0119279995706467
12,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.000215307210163459,0.0119279995706467
13,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,93,Down,0.000217227972504137,0.0119279995706467
14,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.000231970978732806,0.0119279995706467
15,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,26,Down,0.000235988044578877,0.0119279995706467
16,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Down,0.00024563793458225,0.0119279995706467
17,WP_PURINERGIC_SIGNALING,16,Down,0.00024578908206181,0.0119279995706467
18,WP_GPCRS_CLASS_A_RHODOPSINLIKE,47,Down,0.000267800544796461,0.0122741916365045
19,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,28,Down,0.000296148856694728,0.0128590950933237
20,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Down,0.00031383104604071,0.0129087841653031
21,WP_PRION_DISEASE_PATHWAY,29,Down,0.000331935832558631,0.0129087841653031
22,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Down,0.000350169671684943,0.0129087841653031
23,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.000382126106828349,0.0129087841653031
24,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.000384490462685805,0.0129087841653031
25,WP_BURN_WOUND_HEALING,62,Down,0.000394176005472563,0.0129087841653031
26,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.000428142193328369,0.0129087841653031
27,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Down,0.000434154077331787,0.0129087841653031
28,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.000438116311064833,0.0129087841653031
29,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,10,Down,0.000475558562841379,0.0133641721723781
30,WP_CCL18_SIGNALING,23,Down,0.000497623569486884,0.0133641721723781
31,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,26,Down,0.000502168893749963,0.0133641721723781
32,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.00054613173144348,0.0134703799866155
33,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Down,0.000557737020818777,0.0134703799866155
34,WP_MAPK_SIGNALING,157,Down,0.000570639007874442,0.0134703799866155
35,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.000571470666098837,0.0134703799866155
36,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Down,0.000611829029560694,0.0138858794179874
37,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.000622760652685497,0.0138858794179874
38,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.000707084815750328,0.0153511834998426
39,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,25,Down,0.000781132550166315,0.0165239577919797
40,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.000817839698691624,0.0168679437855147
41,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.000854830777924898,0.0170673823532284
42,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,47,Down,0.000868884919800717,0.0170673823532284
43,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Down,0.00100694273473055,0.0193192501430862
44,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Down,0.00109185774618664,0.0204723327409995
45,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.00120623191167996,0.0217059189039875
46,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Down,0.00121026941767688,0.0217059189039875
47,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.00134846012309704,0.0236697787564905
48,WP_IL26_SIGNALING,33,Down,0.00147745648220551,0.0251711241916263
49,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Down,0.00149501222471478,0.0251711241916263
50,WP_LUNG_FIBROSIS,35,Down,0.00155603543234974,0.0256745846337707
51,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,27,Down,0.00164825388685419,0.0266509422737403
52,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.00168068149517084,0.0266509422737403
53,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,11,Down,0.00171212114000998,0.0266509422737403
54,WP_COMPLEMENT_ACTIVATION,11,Up,0.00184889023707301,0.027755901448226
55,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.00188403694678867,0.027755901448226
56,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.00188403694678867,0.027755901448226
57,WP_GASTRIN_SIGNALING,91,Down,0.00224030601283935,0.03242548176478
58,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.00228416192381637,0.0324902342611812
59,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.00271673026654207,0.036767198177138
60,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,6,Up,0.00272275673405335,0.036767198177138
61,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,28,Down,0.00273292216042299,0.036767198177138
62,WP_VEGFAVEGFR2_SIGNALING,338,Down,0.00276311065088794,0.036767198177138
63,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Down,0.00288046253149731,0.0371572696872209
64,WP_CHEMOKINE_SIGNALING,114,Down,0.0028825033454329,0.0371572696872209
65,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.00322585258903209,0.0409435136300226
66,WP_PLEURAL_MESOTHELIOMA,246,Down,0.00328750257708666,0.0410937822135832
67,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.00336143833330419,0.0413908451488949
68,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.00354605192697158,0.0426980796597675
69,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.00357111211699873,0.0426980796597675
70,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.00365203989759463,0.0430418987930796
71,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Down,0.0037483061959387,0.0435542621359075
72,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.0038183104660882,0.0437514740905939
73,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Down,0.00416166512579649,0.0470325168326316
74,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Down,0.00429791533676712,0.0479159480112551
75,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Down,0.00453797785399475,0.0493723597825156
76,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.00454824162844992,0.0493723597825156
77,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.00477335394843458,0.0495081356190947
78,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.00478207677598806,0.0495081356190947
79,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.00481767885025234,0.0495081356190947
80,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,74,Down,0.00488669043970922,0.0495081356190947
81,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Down,0.00491924837604012,0.0495081356190947
82,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.00492080863123123,0.0495081356190947
83,WP_BLADDER_CANCER,30,Down,0.00507774471180235,0.0504715588823727
84,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.00521055721031605,0.0511751154584612
85,WP_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.00549355614055732,0.0526998118134859
86,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.00549355614055732,0.0526998118134859
87,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Down,0.00561617960281493,0.0532568755439347
88,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.00584075191551032,0.0547570492079092
89,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.00591545112306526,0.0548342379385263
90,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.00609189334546603,0.0556657616671655
91,WP_HIPPO_SIGNALING_REGULATION,41,Down,0.00614010219601462,0.0556657616671655
92,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Down,0.00651088955810737,0.0574468524608547
93,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.00652446310406245,0.0574468524608547
94,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.00654545955311557,0.0574468524608547
95,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Down,0.00669412314743267,0.0581098420854408
96,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,6,Down,0.00702378808166551,0.0581098420854408
97,WP_AGERAGE_PATHWAY,55,Down,0.0070487771185653,0.0581098420854408
98,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.00705347603603865,0.0581098420854408
99,WP_PEPTIDE_GPCRS,14,Down,0.00705707645531077,0.0581098420854408
100,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.00706270415467976,0.0581098420854408
101,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.00711405339470246,0.0581098420854408
102,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.00776547704558396,0.0624690190800153
103,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Down,0.007799162382111,0.0624690190800153
104,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.0079439201967313,0.062905568830127
105,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.00800616330565253,0.062905568830127
106,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.00843934594398856,0.0645643727117695
107,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,95,Down,0.00844385711292573,0.0645643727117695
108,WP_OREXIN_RECEPTOR_PATHWAY,112,Down,0.00845206333681346,0.0645643727117695
109,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.00893577190987504,0.0675276465769303
110,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.00902220535555973,0.0675276465769303
111,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.00915708223118538,0.0675276465769303
112,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.00916738959589842,0.0675276465769303
113,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.00996975549344211,0.0724861568568802
114,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,133,Down,0.0100162689474962,0.0724861568568802
115,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Down,0.0101770726685245,0.0726780831662769
116,WP_ASPIRIN_AND_MIRNAS,8,Down,0.0102189789664098,0.0726780831662769
117,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Down,0.0105022759711052,0.0734522154712128
118,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.0105925612223232,0.0734522154712128
119,WP_PDGF_PATHWAY,36,Down,0.0105949256255446,0.0734522154712128
120,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.0107175138498291,0.0736829077175749
121,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Down,0.0109729534177442,0.0748155914846195
122,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.0114131962084217,0.0771794005897372
123,WP_SEROTONIN_AND_ANXIETY,6,Down,0.0118433480378368,0.0794370904976857
124,WP_HEART_DEVELOPMENT,15,Down,0.0119943200335864,0.0798009195782967
125,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0122049863832622,0.0801343247463255
126,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.0122386968703479,0.0801343247463255
127,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.0125029262327489,0.0812197963938414
128,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Up,0.0132054337127738,0.0851131469768622
129,WP_SMALL_LIGAND_GPCRS,7,Down,0.0148759276760496,0.0951367467654334
130,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.0153205520599884,0.09668217529084
131,WP_EGFEGFR_SIGNALING,138,Down,0.0153519575310303,0.09668217529084
132,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.016038912216751,0.100243201354694
133,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,9,Down,0.0161703027860747,0.100304509763245
134,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.016472435536192,0.101416114308645
135,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.0175924939025485,0.107509684960019
136,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.017872541902266,0.108417993157129
137,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.0181550937781328,0.109328119466858
138,WP_RETINOL_METABOLISM,5,Down,0.0184168965271182,0.109929908933703
139,WP_PPAR_SIGNALING,37,Up,0.0185215240506481,0.109929908933703
140,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.0187728624629239,0.110625796656516
141,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.0195589813183339,0.112829553800562
142,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Down,0.0196143207613619,0.112829553800562
143,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.0198163632638019,0.112829553800562
144,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Down,0.019842800137134,0.112829553800562
145,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Up,0.019910521061479,0.112829553800562
146,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Down,0.0199674119453116,0.112829553800562
147,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.0207677239705473,0.116553552895929
148,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.0209686492281051,0.116886051440451
149,WP_NETRINUNC5B_SIGNALING,35,Down,0.0218269353738494,0.120597481243988
150,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.0219268147716342,0.120597481243988
151,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.022820245733253,0.124680150529362
152,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.0231832360786102,0.124841743007093
153,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.0232712879779885,0.124841743007093
154,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.0234235599485033,0.124841743007093
155,WP_MEVALONATE_PATHWAY,7,Down,0.0234551153528478,0.124841743007093
156,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.0237407361889518,0.125551970230034
157,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.0241303146674857,0.126799424208125
158,WP_IL1_SIGNALING,51,Down,0.0243982748137508,0.127396055198383
159,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.0248485032025379,0.128930912843357
160,WP_G_PROTEIN_SIGNALING,60,Down,0.0250719706594699,0.129277348712892
161,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.0260792393816753,0.133584117434417
162,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.0262940013372151,0.133584117434417
163,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.0266222773500169,0.133584117434417
164,WP_TRANSLATION_FACTORS,49,Down,0.0267984684255423,0.133584117434417
165,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.0269368917341601,0.133584117434417
166,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,76,Down,0.0270430429252718,0.133584117434417
167,WP_PROTEASOME_DEGRADATION,57,Down,0.027066954932146,0.133584117434417
168,WP_IL18_SIGNALING,190,Down,0.0272025839139176,0.133584117434417
169,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Down,0.0275677968473308,0.133953332108072
170,WP_ULCERATIVE_COLITIS_SIGNALING,13,Down,0.0276198645102723,0.133953332108072
171,WP_TP53_NETWORK,14,Down,0.0280253551705091,0.133953332108072
172,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0284840312174905,0.133953332108072
173,WP_NUCLEOTIDE_GPCRS,7,Down,0.0285531776510247,0.133953332108072
174,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Up,0.0285589303478745,0.133953332108072
175,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.0287684103765002,0.133953332108072
176,WP_PREIMPLANTATION_EMBRYO,20,Down,0.0288574447485017,0.133953332108072
177,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Up,0.0289982489382283,0.133953332108072
178,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.0292837996161417,0.133953332108072
179,WP_IL19_SIGNALING,20,Down,0.029459880855271,0.133953332108072
180,WP_NEURAL_CREST_DIFFERENTIATION,34,Down,0.0294882487396029,0.133953332108072
181,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.0295394096727127,0.133953332108072
182,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0295509169014171,0.133953332108072
183,WP_ENDODERM_DIFFERENTIATION,82,Down,0.0300396867310363,0.135424817230082
184,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0308357523682989,0.138258128825253
185,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.032362513159018,0.144319315438864
186,WP_ERBB_SIGNALING,68,Down,0.0327614179536555,0.144681636079236
187,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Down,0.0327945041779601,0.144681636079236
188,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.0329767438662516,0.144711774944987
189,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0336186913136852,0.146699074030559
190,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.0337852412918862,0.146699074030559
191,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.0343426216254151,0.148338548905589
192,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Down,0.036331879097315,0.155396891815518
193,WP_MELANOMA,53,Down,0.0363534546913879,0.155396891815518
194,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Down,0.0365918827844327,0.155609810810088
195,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.0375156141610445,0.158719906065958
196,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Down,0.0385420212981165,0.159541170939903
197,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.0385912862262908,0.159541170939903
198,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Up,0.0386187627016546,0.159541170939903
199,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Up,0.0386187627016546,0.159541170939903
200,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.0386766475005825,0.159541170939903
201,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.0402689336190147,0.165282936495956
202,WP_SYNAPTIC_VESICLE_PATHWAY,20,Down,0.0413103723328468,0.168718104824746
203,WP_IRINOTECAN_PATHWAY,5,Up,0.043787634982611,0.177216031592535
204,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,61,Up,0.0438206914483359,0.177216031592535
205,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.0442637147111811,0.178134461642558
206,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Down,0.0449750780086597,0.179132824565562
207,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Down,0.0452345122620647,0.179132824565562
208,WP_NEOVASCULARIZATION_PROCESSES,23,Down,0.0452394644676575,0.179132824565562
209,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.045380315556609,0.179132824565562
210,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.0464121115059321,0.182333295201876
211,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.0467498320125046,0.182789627537044
212,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0475690854808676,0.185115544913753
213,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.0480881248774042,0.186256821708256
214,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.0491325664527339,0.188812233855457
215,WP_HEPATITIS_B_INFECTION,118,Down,0.0493539421427655,0.188812233855457
216,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Down,0.0494344757730651,0.188812233855457
217,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.0499673255731914,0.189565230972619
218,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.0502400045105211,0.189565230972619
219,WP_IL5_SIGNALING,37,Down,0.0503753342596212,0.189565230972619
220,WP_CELL_CYCLE,87,Down,0.050550728259365,0.189565230972619
221,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.0518766510968028,0.193215431467015
222,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.0523991048904613,0.193215431467015
223,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.0524085893211634,0.193215431467015
224,WP_FOCAL_ADHESION,117,Down,0.052460917149832,0.193215431467015
225,WP_RAS_SIGNALING,113,Down,0.0535605568421168,0.196297634731908
226,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,51,Down,0.0541765881164369,0.196297634731908
227,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.0541835710458836,0.196297634731908
228,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.0544444434943712,0.196297634731908
229,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.0544874646710387,0.196297634731908
230,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.0551455299672691,0.197804618360857
231,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.0555572318161435,0.198418685057655
232,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0557997523861667,0.198425843614601
233,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Up,0.0571273342511205,0.202274895953538
234,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.0577550930534913,0.203623725509104
235,WP_GLIOBLASTOMA_SIGNALING,65,Down,0.0580060374696084,0.203638216648625
236,WP_PROLACTIN_SIGNALING,70,Down,0.0583563541467142,0.203999966826437
237,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.0600522328510378,0.209042582709309
238,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.0621897180655127,0.215573602538017
239,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.0629778932474273,0.217392309326893
240,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,27,Down,0.0657283713174999,0.225472448359254
241,WP_ENDOTHELIN_PATHWAYS,12,Down,0.0660053636827575,0.225472448359254
242,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.0661385848520479,0.225472448359254
243,WP_ACUTE_VIRAL_MYOCARDITIS,66,Down,0.0670628216649807,0.22565140371681
244,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Down,0.0671993910123662,0.22565140371681
245,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.067276382839465,0.22565140371681
246,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.0674177496250936,0.22565140371681
247,WP_JOUBERT_SYNDROME,66,Up,0.067558662688548,0.22565140371681
248,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Down,0.0682798579271843,0.227140656410996
249,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.0697870791604971,0.231222250230563
250,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0709257949963763,0.233532832267064
251,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.0710505950291309,0.233532832267064
252,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Down,0.0720746871729881,0.235958797292521
253,WP_PTF1A_RELATED_REGULATORY_PATHWAY,4,Down,0.0723762538088127,0.236009523289607
254,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.0731996456545486,0.237754754586624
255,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Down,0.07438716710635,0.240664364167603
256,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.0764097107664346,0.245417264528885
257,WP_ATR_SIGNALING,10,Up,0.0764846626603563,0.245417264528885
258,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.0768401134468843,0.245417264528885
259,WP_ALLOGRAFT_REJECTION,50,Down,0.0770461472884621,0.245417264528885
260,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.0782504674372901,0.248294752445247
261,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,8,Down,0.0797095653710802,0.251955522724679
262,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,1,Down,0.0813878829699425,0.25579079567702
263,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0815430051673409,0.25579079567702
264,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Down,0.0822321410920436,0.256975440912636
265,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.0831106146025941,0.258740592630718
266,WP_HUNGER_AND_SATIETY,2,Up,0.0850625630089033,0.261861838308002
267,WP_GPCRS_OTHER,13,Down,0.0851488903681843,0.261861838308002
268,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.0853924688021135,0.261861838308002
269,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Down,0.0858826292433347,0.261861838308002
270,WP_BREAST_CANCER_PATHWAY,82,Down,0.0858936614617272,0.261861838308002
271,WP_CYTOSINE_METHYLATION,7,Down,0.0860176462805681,0.261861838308002
272,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.0867383646667437,0.263085113419351
273,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.0872835643516953,0.263251779924939
274,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.0874315002417373,0.263251779924939
275,WP_LEPTIN_SIGNALING,70,Down,0.0893590400104051,0.267150683707888
276,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.0893740469131844,0.267150683707888
277,WP_IL2_SIGNALING,37,Down,0.0903275187363621,0.269026003456674
278,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.0912709709680608,0.270858097297303
279,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Down,0.091735425682257,0.271260667340007
280,WP_DRAVET_SYNDROME,12,Down,0.0921639906046912,0.27135896995623
281,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.0924375100724845,0.27135896995623
282,WP_MONOAMINE_TRANSPORT,11,Down,0.0928224372177688,0.27135896995623
283,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.0930843496940764,0.27135896995623
284,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,120,Down,0.0935915562303156,0.271876879894403
285,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Down,0.0948805357127665,0.27430320132814
286,WP_TRYPTOPHAN_METABOLISM,17,Up,0.0950917764604219,0.27430320132814
287,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,35,Down,0.0962181365313646,0.276585235673783
288,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Up,0.097335509394283,0.278825677952373
289,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.0981331586024662,0.28013790950531
290,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.100514355864326,0.283848029150385
291,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.10065525521506,0.283848029150385
292,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Down,0.100683132384282,0.283848029150385
293,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,54,Up,0.100809057625531,0.283848029150385
294,WP_CANCER_PATHWAYS,292,Down,0.101666795895715,0.285289478278791
295,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.10371474638638,0.289534328032784
296,WP_SMALL_CELL_LUNG_CANCER,64,Down,0.103881407391156,0.289534328032784
297,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.104514396499285,0.289864781652108
298,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.104702672645246,0.289864781652108
299,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.106074417703383,0.291953262948507
300,WP_REGULATION_OF_ACTIN_CYTOSKELETON,88,Down,0.106164822890366,0.291953262948507
301,WP_IL7_SIGNALING,24,Down,0.108390676547812,0.297084080239019
302,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Down,0.1089097811716,0.297518441942285
303,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.10960239688003,0.298422367742657
304,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,8,Down,0.110360938231787,0.299499256714554
305,WP_SILDENAFIL_TREATMENT,11,Down,0.111576461913548,0.301805183864515
306,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.113887704367757,0.307050183344443
307,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.116181417610043,0.312213907258258
308,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.117365064606436,0.31437070876724
309,WP_MONOAMINE_GPCRS,4,Down,0.121620385110999,0.324150630074791
310,WP_PI3KAKT_SIGNALING,174,Down,0.1218404142024,0.324150630074791
311,WP_THERMOGENESIS,75,Down,0.12219496479183,0.324150630074791
312,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.123880065107602,0.327567479851831
313,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,81,Down,0.125090355875485,0.328971254917975
314,WP_OSTEOPONTIN_SIGNALING,12,Down,0.125208453386963,0.328971254917975
315,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.125782150143818,0.329429440852857
316,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.128862179035144,0.335613330830466
317,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,13,Up,0.128956879846373,0.335613330830466
318,WP_MRNA_PROCESSING,124,Down,0.131527690516316,0.339611850991637
319,WP_WNT_SIGNALING_WP428,58,Down,0.13163350333657,0.339611850991637
320,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Down,0.131740209828075,0.339611850991637
321,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.132536031993126,0.339611850991637
322,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.132551534568857,0.339611850991637
323,WP_VITAMIN_B12_METABOLISM,24,Down,0.134000009798757,0.341118500304354
324,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.134191361640727,0.341118500304354
325,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Down,0.134380015271412,0.341118500304354
326,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.137153408256348,0.347090680403334
327,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.139635957854327,0.352130068513764
328,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.139998378754563,0.352130068513764
329,WP_MATRIX_METALLOPROTEINASES,10,Down,0.140792640250416,0.353051453515481
330,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,49,Down,0.141514481130833,0.353786202827082
331,WP_SULINDAC_METABOLIC_PATHWAY,3,Up,0.142313472004654,0.354708804845436
332,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.143562950200526,0.356745282877814
333,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.144592640332193,0.358225009832009
334,WP_ATM_SIGNALING,32,Down,0.145279422165245,0.358806970811569
335,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.146112134639211,0.358806970811569
336,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Down,0.146787336947681,0.358806970811569
337,WP_OVARIAN_INFERTILITY,21,Down,0.147313339285102,0.358806970811569
338,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.147372297161898,0.358806970811569
339,WP_PURINE_METABOLISM,10,Down,0.147437046188026,0.358806970811569
340,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.14814248460123,0.359065972760485
341,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Up,0.149108418172044,0.359065972760485
342,WP_ALZHEIMERS_DISEASE,183,Down,0.149284398371935,0.359065972760485
343,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Down,0.149284398371935,0.359065972760485
344,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.150585985500115,0.361143715225568
345,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Down,0.151310450619703,0.36182933843842
346,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.15265365410531,0.363470849439836
347,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.152878042128028,0.363470849439836
348,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.153573664695992,0.364075498201705
349,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Down,0.154016544820683,0.364079224862647
350,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,27,Down,0.154826528431549,0.364948245588652
351,WP_BARDETBIEDL_SYNDROME,61,Up,0.157792886508013,0.370880716151313
352,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,16,Down,0.159133353876443,0.372919460347142
353,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.159910969224181,0.372919460347142
354,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.160016350258047,0.372919460347142
355,WP_CAMKK2_PATHWAY,29,Down,0.161286940066721,0.374821762126887
356,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.162599003745218,0.376240159585259
357,WP_MAPK_CASCADE,30,Down,0.162947069164984,0.376240159585259
358,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.163408297720215,0.376240159585259
359,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.163721475504373,0.376240159585259
360,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Down,0.164861007014782,0.377806474408874
361,WP_RANKLRANK_SIGNALING,47,Down,0.167374092131126,0.38250311913623
362,WP_DOPAMINE_METABOLISM,7,Down,0.168318833614965,0.383599551746813
363,WP_LIPID_PARTICLES_COMPOSITION,4,Up,0.169908973848162,0.386156758745822
364,WP_G13_SIGNALING,30,Down,0.171683232627632,0.388345467372327
365,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.17181344920109,0.388345467372327
366,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.173101157673457,0.390187035739351
367,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.174287233704839,0.391790103014964
368,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.176301540458276,0.394579402905608
369,WP_DNA_DAMAGE_RESPONSE,56,Down,0.176484605663236,0.394579402905608
370,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.177859310485811,0.395027677984787
371,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.177924497933316,0.395027677984787
372,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.178121571164049,0.395027677984787
373,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.178723951946979,0.395300966102568
374,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.179220302929994,0.395338903522046
375,WP_MACROPHAGE_MARKERS,8,Up,0.180178189958456,0.396392017908603
376,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.182038265530731,0.397263887175721
377,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Down,0.182289204139148,0.397263887175721
378,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Down,0.182677860257188,0.397263887175721
379,WP_OSTEOBLAST_SIGNALING,2,Down,0.183121423234967,0.397263887175721
380,WP_10Q22Q23_COPY_NUMBER_VARIATION,26,Down,0.183235712014468,0.397263887175721
381,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.183463686077515,0.397263887175721
382,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.185054187395436,0.399658912568678
383,WP_15Q25_COPY_NUMBER_VARIATION,26,Up,0.189878607131894,0.409007443560867
384,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Down,0.191190570250491,0.410760990772539
385,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.191797228221043,0.410837968085632
386,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.192719399802011,0.410837968085632
387,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.192720355938351,0.410837968085632
388,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Down,0.195218744422834,0.415091402445458
389,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Down,0.196546419235593,0.415970536097592
390,WP_TNFALPHA_SIGNALING,81,Down,0.197634340431937,0.415970536097592
391,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.197861086006995,0.415970536097592
392,WP_ENDOMETRIAL_CANCER,48,Down,0.198062270230481,0.415970536097592
393,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Down,0.198212186771843,0.415970536097592
394,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.198657443906001,0.415970536097592
395,WP_NOTCH_SIGNALING_WP61,48,Down,0.201224973672733,0.420280008303809
396,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,80,Up,0.202879021523317,0.422664628173577
397,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,57,Down,0.203777362565704,0.423301605108341
398,WP_TAR_SYNDROME,44,Down,0.204210956161357,0.423301605108341
399,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.205908010171054,0.425749645090525
400,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.206798441300189,0.426048934159464
401,WP_KIT_RECEPTOR_SIGNALING,51,Down,0.207085603149025,0.426048934159464
402,WP_PHOSPHOINOSITIDES_METABOLISM,37,Up,0.21072680317957,0.431645095301467
403,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.211332645832067,0.431645095301467
404,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.211375295153688,0.431645095301467
405,WP_WNT_SIGNALING_WP363,40,Down,0.212232550275558,0.431727152719826
406,WP_SERINE_METABOLISM,7,Down,0.21246208970212,0.431727152719826
407,WP_DNA_MISMATCH_REPAIR,21,Up,0.21675492608905,0.436204242792133
408,WP_GASTRIC_CANCER_NETWORK_2,25,Down,0.218224472029262,0.436204242792133
409,WP_13Q1212_COPY_NUMBER_VARIATION,17,Down,0.218493772571255,0.436204242792133
410,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.218854003443879,0.436204242792133
411,WP_INSULIN_SIGNALING,126,Down,0.219002509694936,0.436204242792133
412,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.219434485099715,0.436204242792133
413,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.219498892419167,0.436204242792133
414,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.219619467803314,0.436204242792133
415,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Down,0.219631847497669,0.436204242792133
416,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.219952684850336,0.436204242792133
417,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Up,0.221558803333572,0.437789653590653
418,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Down,0.221813424485931,0.437789653590653
419,WP_NUCLEAR_RECEPTORS_METAPATHWAY,174,Down,0.22748211392104,0.447906310226391
420,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,58,Down,0.228604525987306,0.449044604617923
421,WP_MINERALOCORTICOID_BIOSYNTHESIS,2,Up,0.234311722035939,0.458100205562038
422,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.234325196057188,0.458100205562038
423,WP_IL17_SIGNALING,24,Down,0.235621155355727,0.459085379891675
424,WP_IL3_SIGNALING,45,Down,0.236439236270652,0.459085379891675
425,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Down,0.236871350872376,0.459085379891675
426,WP_CILIOPATHIES,114,Up,0.237054996162247,0.459085379891675
427,WP_ESTROGEN_SIGNALING,21,Down,0.240386215022802,0.464446434177544
428,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.242899546359596,0.468205901277259
429,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.246236707927097,0.472485133917824
430,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Down,0.246264978890502,0.472485133917824
431,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.247063186363254,0.472916772041031
432,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,28,Down,0.24800007995782,0.473611263808338
433,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.250360621384217,0.476054132243259
434,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Down,0.250457674729819,0.476054132243259
435,WP_AXON_GUIDANCE,33,Down,0.251010360637355,0.476054132243259
436,WP_IL11_SIGNALING,39,Down,0.253375683586665,0.478277431298897
437,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,41,Down,0.253475356792899,0.478277431298897
438,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.254062183390494,0.478277431298897
439,WP_TYPE_II_INTERFERON_SIGNALING,31,Down,0.254501566472989,0.478277431298897
440,WP_GLUCURONIDATION,7,Up,0.256971529851933,0.481821618472374
441,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.258038038048785,0.482460895809138
442,WP_COMPLEMENT_SYSTEM,52,Up,0.258713169676619,0.482460895809138
443,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.259066881022361,0.482460895809138
444,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,13,Down,0.262584395466995,0.487860226022345
445,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Down,0.263148849187811,0.487860226022345
446,WP_GASTRIC_CANCER_NETWORK_1,16,Up,0.265393737742213,0.490772201309481
447,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.26590930180041,0.490772201309481
448,WP_15Q11Q13_COPY_NUMBER_VARIATION,28,Up,0.269837502683681,0.496910579718832
449,WP_NEUROINFLAMMATION,10,Down,0.272063480480469,0.499368506845401
450,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.272382821915673,0.499368506845401
451,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.273114261527376,0.499599258891542
452,WP_APOPTOSIS_MODULATION_AND_SIGNALING,73,Down,0.276274307659719,0.503530278646842
453,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.276742345330465,0.503530278646842
454,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.277197969638235,0.503530278646842
455,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.277704577920379,0.503530278646842
456,WP_NRXN1_DELETION_SYNDROME,2,Up,0.278831975725748,0.504465745556452
457,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.279629178300591,0.504801033037172
458,WP_TAMOXIFEN_METABOLISM,3,Up,0.281652482557445,0.507343445654787
459,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.28230582347026,0.507412427806023
460,WP_NAD_METABOLISM,11,Down,0.287376303804085,0.515403153561673
461,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Down,0.288162513829735,0.515692134293995
462,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.29005237468974,0.517043564761899
463,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Down,0.290171115739102,0.517043564761899
464,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Up,0.295437570968343,0.525293094932938
465,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,36,Up,0.296475767241564,0.526005393493098
466,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.298761899584214,0.528144677662293
467,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.298961896325201,0.528144677662293
468,WP_AEROBIC_GLYCOLYSIS,9,Down,0.301591861601052,0.530518733093536
469,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Down,0.301591861601052,0.530518733093536
470,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.304520164286508,0.53373824378931
471,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Up,0.30471601554517,0.53373824378931
472,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,14,Up,0.308845833767864,0.539825874700186
473,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Up,0.311884914093102,0.543985315278665
474,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Down,0.313488361419953,0.544596892177104
475,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.313878437198047,0.544596892177104
476,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Down,0.314234543106206,0.544596892177104
477,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.314876021295125,0.544596892177104
478,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.316724484366656,0.546647907118183
479,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.317547239816923,0.54692374289971
480,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.31865746357549,0.547692515520374
481,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,33,Down,0.320248304862256,0.548486421554915
482,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.320449036593296,0.548486421554915
483,WP_MALE_INFERTILITY,71,Down,0.322025352494933,0.550043303950972
484,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.32468721574577,0.553444117748471
485,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.32706458992895,0.555709692518075
486,WP_KREBS_CYCLE_DISORDERS,11,Up,0.327363527956102,0.555709692518075
487,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.332107183472163,0.56260457159042
488,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.333479711660411,0.56266739003854
489,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.333508307550117,0.56266739003854
490,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,2,Up,0.334640994248875,0.563426163786372
491,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.339984719496444,0.571257420742498
492,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.344097596387461,0.575838097399913
493,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Down,0.344106887294736,0.575838097399913
494,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.345605888644953,0.57699041528382
495,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,49,Down,0.346194249170292,0.57699041528382
496,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.349508653039901,0.581339997495803
497,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,163,Down,0.352448268876219,0.584292723096853
498,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.353380954724749,0.584292723096853
499,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.353883696735003,0.584292723096853
500,WP_ANGIOGENESIS,14,Down,0.35411680187688,0.584292723096853
501,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,9,Down,0.355733415248505,0.585788558043946
502,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Down,0.358554208847194,0.588204352673805
503,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.358626411387787,0.588204352673805
504,WP_FRAGILE_X_SYNDROME,83,Down,0.359880472069175,0.588666702580623
505,WP_CREATINE_PATHWAY,2,Down,0.360335375519048,0.588666702580623
506,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,24,Down,0.363111362781132,0.592029395838803
507,WP_NOTCH_SIGNALING_WP268,33,Down,0.366743551507582,0.596772051269734
508,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.370310176127503,0.59816455274553
509,WP_P38_MAPK_SIGNALING,31,Down,0.370453525179067,0.59816455274553
510,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.370567045471734,0.59816455274553
511,WP_FLUOROPYRIMIDINE_ACTIVITY,26,Down,0.370593270241814,0.59816455274553
512,WP_BLOOD_CLOTTING_CASCADE,6,Down,0.37122454667359,0.59816455274553
513,WP_ID_SIGNALING,11,Down,0.376326006229442,0.604340331514478
514,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,25,Down,0.376522339876899,0.604340331514478
515,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Down,0.378415560552133,0.606199684379631
516,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.381101199476706,0.609318778233106
517,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.382472063009643,0.610327760121771
518,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.38598975710501,0.614752026277284
519,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Down,0.391354043844449,0.622094578365454
520,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Down,0.39369785445827,0.623799298868361
521,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.393938708739898,0.623799298868361
522,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Down,0.394706148402704,0.623817188567491
523,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.395842760176208,0.624417355918492
524,WP_VALPROIC_ACID_PATHWAY,8,Up,0.397749275787981,0.626227390315046
525,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Down,0.400018833872656,0.62761221952448
526,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Down,0.400150336327123,0.62761221952448
527,WP_ARYLAMINE_METABOLISM,1,Up,0.402620745180386,0.629009379830221
528,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,4,Down,0.403296416372971,0.629009379830221
529,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.403729613500889,0.629009379830221
530,WP_IL4_SIGNALING,50,Down,0.404090874315172,0.629009379830221
531,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.411470300986446,0.637654623693283
532,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.411747812225689,0.637654623693283
533,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Down,0.412160529982349,0.637654623693283
534,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.412736447336016,0.637654623693283
535,WP_SPHINGOLIPID_PATHWAY,21,Down,0.418322395924027,0.644443503582723
536,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.418692991418593,0.644443503582723
537,WP_ENERGY_METABOLISM,41,Down,0.424517910761102,0.652138161851544
538,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.425273128577128,0.652138161851544
539,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Up,0.427490996627771,0.654063432602516
540,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Down,0.428114246794374,0.654063432602516
541,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.430006064023602,0.655739376745788
542,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.434081184641403,0.6607324304966
543,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.44220077062573,0.671851999569479
544,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.445305291779345,0.674587537196202
545,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.445712320336977,0.674587537196202
546,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.446454297344396,0.674587537196202
547,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.449121589097067,0.677377168199415
548,WP_NEPHROGENESIS,3,Down,0.454081538874131,0.682442264431093
549,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.454134306875964,0.682442264431093
550,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.45804387385859,0.687065810787885
551,WP_NEPHROTIC_SYNDROME,26,Up,0.464454722200149,0.69541768750476
552,WP_NONSMALL_CELL_LUNG_CANCER,58,Down,0.465611027207145,0.695595502907159
553,WP_MESODERMAL_COMMITMENT_PATHWAY,74,Down,0.466259773463829,0.695595502907159
554,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.467790870692063,0.696619978918686
555,WP_DNA_REPLICATION,34,Up,0.473309446566665,0.703173700755193
556,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.473896457721076,0.703173700755193
557,WP_BDNFTRKB_SIGNALING,26,Down,0.475926864237589,0.704918605019769
558,WP_PANCREATIC_CANCER_SUBTYPES,4,Down,0.482560971342489,0.713463801716046
559,WP_NRF2ARE_REGULATION,21,Up,0.484061660286256,0.71369241183018
560,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Down,0.484808415529651,0.71369241183018
561,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,15,Up,0.485310840044522,0.71369241183018
562,WP_HISTONE_MODIFICATIONS,35,Up,0.488205581943824,0.715989928966543
563,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,11,Down,0.48860888485838,0.715989928966543
564,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.497572873525807,0.727295673515583
565,WP_GLUTATHIONE_METABOLISM,10,Up,0.499556376891609,0.727295673515583
566,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Up,0.4997368648323,0.727295673515583
567,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,164,Down,0.49985048107071,0.727295673515583
568,WP_IL6_SIGNALING,39,Down,0.505655841168505,0.733371137759127
569,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Up,0.506638339383344,0.733371137759127
570,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.507017205260511,0.733371137759127
571,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.508234888901012,0.733371137759127
572,WP_IDO_METABOLIC_PATHWAY,6,Up,0.508470655512995,0.733371137759127
573,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Down,0.511259828128374,0.735885913770156
574,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.511998199398872,0.735885913770156
575,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.516235462933162,0.739121645011681
576,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.516335700633273,0.739121645011681
577,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.518352528866651,0.739121645011681
578,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Down,0.518666433915528,0.739121645011681
579,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Up,0.518729009044561,0.739121645011681
580,WP_CIRCADIAN_RHYTHM_GENES,113,Down,0.521175383039611,0.740720916868836
581,WP_KLEEFSTRA_SYNDROME,25,Up,0.522080890994487,0.740720916868836
582,WP_FOLATE_METABOLISM,36,Down,0.522544937718379,0.740720916868836
583,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,11,Down,0.524113385852391,0.741669885640175
584,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.525707214613521,0.742651459000266
585,WP_CHOLESTASIS,9,Up,0.528970986583447,0.743573378384933
586,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,13,Down,0.528983687516513,0.743573378384933
587,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.529063724984188,0.743573378384933
588,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.530395628860732,0.744177540493375
589,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.534609879405718,0.747863663549309
590,WP_PYRIMIDINE_METABOLISM,71,Down,0.535840157495467,0.747863663549309
591,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.536610646581066,0.747863663549309
592,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.536648834934777,0.747863663549309
593,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.539684508403328,0.750825833782034
594,WP_ECTODERM_DIFFERENTIATION,72,Down,0.541933920902676,0.752528176365313
595,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.543197711351685,0.752528176365313
596,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.543644597713608,0.752528176365313
597,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.545404565225406,0.753699776065259
598,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.548381908779781,0.755110819781378
599,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.549160822494297,0.755110819781378
600,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.549171505295548,0.755110819781378
601,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Down,0.550664684750719,0.7559041013633
602,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Up,0.555508751355365,0.760405349354209
603,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.556048534484605,0.760405349354209
604,WP_GPR40_PATHWAY,7,Down,0.556708886072657,0.760405349354209
605,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Down,0.560449290230912,0.763473632535859
606,WP_EICOSANOID_SYNTHESIS,13,Down,0.560806086444522,0.763473632535859
607,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.562135766712574,0.764023076668654
608,WP_MEASLES_VIRUS_INFECTION,99,Down,0.563717438102893,0.764138559041583
609,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.56407319085615,0.764138559041583
610,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.56743843643086,0.7663924665099
611,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.567594905500059,0.7663924665099
612,WP_RETT_SYNDROME,30,Down,0.569976347264064,0.768175119971365
613,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Down,0.571681575143215,0.768175119971365
614,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Up,0.571708513530204,0.768175119971365
615,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.578143467554411,0.771733117612
616,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.579027484836718,0.771733117612
617,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Up,0.580515868828273,0.771733117612
618,WP_IRON_METABOLISM_IN_PLACENTA,9,Up,0.581399967887423,0.771733117612
619,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,38,Down,0.581957849665927,0.771733117612
620,WP_APOPTOSIS,69,Down,0.582850073479076,0.771733117612
621,WP_TGFB_SMAD_SIGNALING,6,Down,0.583030785093125,0.771733117612
622,WP_GLYOXYLATE_METABOLISM,5,Up,0.583099882039367,0.771733117612
623,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.583655282469134,0.771733117612
624,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.583710867139258,0.771733117612
625,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Down,0.587429681595787,0.775407179706439
626,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.589726185188874,0.777195052365529
627,WP_G1_TO_S_CELL_CYCLE_CONTROL,48,Down,0.595516663244557,0.783574556900733
628,WP_AUTOPHAGY,27,Down,0.597259727176125,0.784437395496631
629,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.598573562791597,0.784437395496631
630,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.599233326794406,0.784437395496631
631,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.59997575340409,0.784437395496631
632,WP_NUCLEAR_RECEPTORS,21,Down,0.602997495521206,0.787140718045878
633,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,26,Down,0.604562322876219,0.787547099333515
634,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.605218013305998,0.787547099333515
635,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.611312448545815,0.794224834724878
636,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.619119557987313,0.803103200219392
637,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.620788637999379,0.804004122997626
638,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.624449766722817,0.807177407647037
639,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.626132624846638,0.807177407647037
640,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Down,0.62617398896255,0.807177407647037
641,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.627538995938466,0.807674994772597
642,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.630514027985334,0.810239989233489
643,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.632808100202622,0.810662550725408
644,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.632808100202622,0.810662550725408
645,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Down,0.637191202480394,0.814051685649346
646,WP_MIRNA_BIOGENESIS,6,Down,0.637427138096336,0.814051685649346
647,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.641022417443216,0.816442797382727
648,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Down,0.641881370633672,0.816442797382727
649,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.642715597481056,0.816442797382727
650,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.644215788704015,0.816442797382727
651,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.644793114755706,0.816442797382727
652,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.645300167535727,0.816442797382727
653,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.646226844473843,0.816442797382727
654,WP_PPARALPHA_PATHWAY,15,Up,0.659308409213594,0.831696387769442
655,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.660831305983231,0.832344774711703
656,WP_KININKALLIKREIN_PATHWAY,2,Down,0.66640369338872,0.836262808941501
657,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.666493033958012,0.836262808941501
658,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Up,0.666982943373949,0.836262808941501
659,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.668960566079723,0.837469600934403
660,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,10,Up,0.671029176627179,0.838786470783973
661,WP_KALLMANN_SYNDROME,11,Down,0.672907976443599,0.839862451688304
662,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.674333115947018,0.840259751817143
663,WP_FOXA2_PATHWAY,9,Up,0.675263291460322,0.840259751817143
664,WP_BENZOAPYRENE_METABOLISM,4,Up,0.676752545346544,0.840844653480269
665,WP_AMINO_ACID_METABOLISM,57,Up,0.680941661437384,0.842404355302351
666,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.681762898025985,0.842404355302351
667,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,27,Up,0.68264505068527,0.842404355302351
668,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.682849199965667,0.842404355302351
669,WP_INTEGRATED_CANCER_PATHWAY,37,Down,0.683113349936088,0.842404355302351
670,WP_VITAMIN_D_METABOLISM,6,Down,0.686111509483037,0.844289737806004
671,WP_STEROID_BIOSYNTHESIS,2,Up,0.686688986748883,0.844289737806004
672,WP_ADIPOGENESIS,80,Down,0.687955535432801,0.844588268946519
673,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.689919037302133,0.845740276039019
674,WP_CILIARY_LANDSCAPE,180,Down,0.698175200669786,0.854591306457825
675,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.703582724570145,0.859934441141289
676,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Down,0.711637712968427,0.868492771004367
677,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.719808894782534,0.876701441422969
678,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.720489184587604,0.876701441422969
679,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,4,Down,0.721952338792565,0.87718804050643
680,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.727457825301288,0.882577508637592
681,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.730920644476147,0.883209727926777
682,WP_PRIMARY_OVARIAN_INSUFFICIENCY,87,Down,0.731294105457974,0.883209727926777
683,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.732185860716032,0.883209727926777
684,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.732261156244746,0.883209727926777
685,WP_ESTROGEN_RECEPTOR_PATHWAY,9,Down,0.734726187370904,0.884889203767877
686,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.737190285219001,0.885956531554361
687,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Up,0.738055656305925,0.885956531554361
688,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.738834052981092,0.885956531554361
689,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.74081362656911,0.887040989723535
690,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,20,Up,0.746007872790509,0.891965934858217
691,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,40,Up,0.748531933520856,0.893688632640675
692,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,64,Down,0.750762000252733,0.894319517661394
693,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.752851835768537,0.894319517661394
694,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.753131772849749,0.894319517661394
695,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Down,0.753396442151114,0.894319517661394
696,WP_HIPPOYAP_SIGNALING,15,Down,0.759461056046038,0.90022323453733
697,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,16,Down,0.761678931546583,0.900995515167729
698,WP_TYPE_II_DIABETES_MELLITUS,12,Up,0.762296811620697,0.900995515167729
699,WP_METHYLATION_PATHWAYS,5,Up,0.765739820060398,0.901348984483535
700,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.765935758145879,0.901348984483535
701,WP_ALPHA_6_BETA_4_SIGNALING,24,Up,0.766024281387439,0.901348984483535
702,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.767134690914146,0.901348984483535
703,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.768058589202333,0.901348984483535
704,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.76962969909537,0.901909803627387
705,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.775703350515593,0.906673678487012
706,WP_TRANSSULFURATION_PATHWAY,8,Up,0.775892869105249,0.906673678487012
707,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.779638009829761,0.908655743789049
708,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.779791838306239,0.908655743789049
709,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.786381409986273,0.914722821427206
710,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.787216003894929,0.914722821427206
711,WP_ZINC_HOMEOSTASIS,20,Down,0.791533751026166,0.917663226766877
712,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.791971172676383,0.917663226766877
713,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.79482182575752,0.918343256507132
714,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.795624571921466,0.918343256507132
715,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,23,Up,0.796733540464578,0.918343256507132
716,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.797010632314069,0.918343256507132
717,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,47,Down,0.80348079821026,0.922671969921846
718,WP_PDGFRBETA_PATHWAY,27,Down,0.804662773585775,0.922671969921846
719,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,11,Up,0.804816182406665,0.922671969921846
720,WP_IRON_METABOLISM_DISORDERS,12,Down,0.806166645296222,0.922671969921846
721,WP_CELLULAR_PROTEOSTASIS,6,Up,0.806359382198365,0.922671969921846
722,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.809428808891207,0.92342214199173
723,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.809694831546088,0.92342214199173
724,WP_CHOLESTEROL_METABOLISM,49,Down,0.810372885820622,0.92342214199173
725,WP_RETINOBLASTOMA_GENE_IN_CANCER,65,Down,0.813784007486843,0.925525827605785
726,WP_ETHER_LIPID_BIOSYNTHESIS,15,Up,0.81658994724902,0.925525827605785
727,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.817365789940586,0.925525827605785
728,WP_CORI_CYCLE,11,Up,0.81843875430284,0.925525827605785
729,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Down,0.818611993954164,0.925525827605785
730,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.820483237595538,0.925525827605785
731,WP_GLUCOCORTICOID_BIOSYNTHESIS,3,Up,0.821293037583724,0.925525827605785
732,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.821549534255191,0.925525827605785
733,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.82231567470914,0.925525827605785
734,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.827423249268286,0.928610602989631
735,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.827495888933946,0.928610602989631
736,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.828433216727719,0.928610602989631
737,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Down,0.829858669212352,0.928946271506364
738,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Down,0.831478173064092,0.929497957693599
739,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.835888467387753,0.932912963790649
740,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Up,0.837747050594068,0.932912963790649
741,WP_NRF2_PATHWAY,69,Up,0.837925462022874,0.932912963790649
742,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,18,Down,0.841149849575354,0.935240735713836
743,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.844207700311621,0.935714955821757
744,WP_OSTEOCLAST_SIGNALING,9,Down,0.8443881131452,0.935714955821757
745,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.845336549076483,0.935714955821757
746,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,268,Down,0.846615658354942,0.935714955821757
747,WP_OXIDATION_BY_CYTOCHROME_P450,16,Down,0.849259360955224,0.935714955821757
748,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.849515759891511,0.935714955821757
749,WP_HEME_BIOSYNTHESIS,8,Down,0.849515759891511,0.935714955821757
750,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.851401775517948,0.936541953069743
751,WP_SELENIUM_MICRONUTRIENT_NETWORK,50,Down,0.85500965566854,0.939110516554268
752,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.856013464786436,0.939110516554268
753,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.859791505640103,0.942002645621626
754,WP_IL9_SIGNALING,15,Down,0.864087199729481,0.942799841798199
755,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Down,0.864574637978857,0.942799841798199
756,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,11,Up,0.86530132778034,0.942799841798199
757,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.866998401958498,0.942799841798199
758,WP_ESTROGEN_METABOLISM_WP697,6,Down,0.868342101306491,0.942799841798199
759,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.868685202701565,0.942799841798199
760,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.870104619941415,0.942799841798199
761,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.870243284314972,0.942799841798199
762,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.870804217515427,0.942799841798199
763,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.872280793503898,0.943160753133311
764,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,20,Down,0.875308154589428,0.944518696278837
765,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.875826427458558,0.944518696278837
766,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.877871984913265,0.945488756597185
767,WP_MTHFR_DEFICIENCY,18,Down,0.881221344648045,0.947858682313738
768,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,8,Down,0.883554589469385,0.949130906656566
769,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Down,0.885603760583944,0.950095061744803
770,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.888879132464723,0.952370499069346
771,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.89423363562389,0.95513721896213
772,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,2,Up,0.895427720922895,0.95513721896213
773,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.895427720922895,0.95513721896213
774,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.896092372699017,0.95513721896213
775,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.898970364885649,0.956388139708038
776,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.899584480501136,0.956388139708038
777,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Up,0.901875605700347,0.957340810843984
778,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.902801394953479,0.957340810843984
779,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.905802057649027,0.958794958545854
780,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.90649705171608,0.958794958545854
781,WP_SLEEP_REGULATION,10,Up,0.911400436468008,0.959653556526974
782,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.911416668750496,0.959653556526974
783,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.911621872682556,0.959653556526974
784,WP_FERROPTOSIS,48,Down,0.91303241533616,0.959653556526974
785,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.915923781093157,0.959653556526974
786,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.916126142719928,0.959653556526974
787,WP_ALSTROM_SYNDROME,26,Up,0.916958959959298,0.959653556526974
788,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,16,Down,0.917222974446525,0.959653556526974
789,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.917951495465845,0.959653556526974
790,WP_5Q35_COPY_NUMBER_VARIATION,75,Down,0.918940981401587,0.959653556526974
791,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.924664236094257,0.964409601488954
792,WP_COPPER_HOMEOSTASIS,39,Up,0.929844887045752,0.968588424005992
793,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Up,0.931629641700284,0.968786332833739
794,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,60,Down,0.932383452448471,0.968786332833739
795,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.937580329169512,0.972960718949493
796,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.944217076476288,0.97328353003127
797,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Down,0.944649291841511,0.97328353003127
798,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Up,0.945082827615325,0.97328353003127
799,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.945807816121443,0.97328353003127
800,WP_NPHP1_DELETION_SYNDROME,10,Down,0.945952433308015,0.97328353003127
801,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.94670090982777,0.97328353003127
802,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,1,Up,0.948383760655479,0.97328353003127
803,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.950137384680558,0.97328353003127
804,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.950377463717236,0.97328353003127
805,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,20,Up,0.952071962889314,0.97328353003127
806,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.952356361707817,0.97328353003127
807,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.953227990624565,0.97328353003127
808,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.953227990624565,0.97328353003127
809,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.956954061717975,0.975136459723273
810,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,69,Down,0.957406705910123,0.975136459723273
811,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.958595006150366,0.975142885418067
812,WP_BENZENE_METABOLISM,3,Down,0.9647840248462,0.980230074505067
813,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Down,0.966494690666272,0.980760294956549
814,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.969676642023945,0.98189380303531
815,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.969992059968216,0.98189380303531
816,WP_ONECARBON_METABOLISM,22,Down,0.977865001100246,0.988650276847675
817,WP_BASE_EXCISION_REPAIR,29,Up,0.981209740265191,0.990817669178437
818,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.985859301009031,0.994295749795171
819,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,9,Down,0.987575834303134,0.994446501200938
820,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.988419552708811,0.994446501200938
821,WP_VITAMIN_B12_DISORDERS,9,Up,0.991962794367692,0.995696235532807
822,WP_SPINA_BIFIDA,10,Up,0.992075521949051,0.995696235532807
823,WP_FOXP3_IN_COVID19,9,Down,0.994748228080958,0.997165599230608
824,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.997397525207121,0.998607959096935
825,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.99899610983907,0.99899610983907
